Archive for the ‘Policy’ Category

EKHA launches a call to action to improve CKD prevention, treatment and care in the aftermath of COVID-19

Today, on 26th February 2021, EKHA launched a call to action calling on EU leaders to improve CKD prevention, treatment and care in the aftermath of COVID-19. This call to action, which has been endorsed by 89 stakeholders, urges policy makers to include four key recommendations in future EU policies and initiatives to address the long-term challenges surrounding CKD in Europe:

  1. Augment efforts on CKD prevention;
  2. Collect and share data on CKD at EU level;
  3. Promote home therapies, transplantation and the uptake of digital tools;
  4. Make research and innovation in Kidney Replacement Therapy an EU priority.

75 million people suffer from CKD in the EU, and projections estimate that CKD will be the 5th leading cause of death worldwide by 2040. Hence, it is expected that CKD will be one of the greatest public health challenges in the next decades.

COVID-19 further emphasized the vulnerability of CKD patients. Studies found that they have a higher mortality risk and are among the patient groups most impacted by medicines shortages and treatment interruptions. Hence, the pandemic has showed the importance of addressing shortcomings in CKD prevention, treatment and care. It is now essential that these are addressed at the political level to limit avoidable deaths in current and future health emergencies.

Read the call to action here.

EKHA meets with EU Commissioner for Health Stella Kyriakides to discuss challenges of Chronic Kidney Disease at the EU level

Today, the 26th February 2021, EKHA, together with the European Kidney Patients’ Federation (EKPF) met with EU Commissioner for Health Stella Kyriakides to discuss the unmet needs and challenges around Chronic Kidney Disease (CKD) in Europe.

During this meeting, EKHA & EKPF discussed the growing and alarming burden of CKD and the long-standing challenges faced by CKD patients in the EU, paying particular attention to the impact of COVID-19.  Further, EKHA seized the occasion to share its Call to Action to improve prevention, treatment and care of CKD in the aftermath of COVID-19, also launched today.

During the meeting, Commissioner Kyriakides was remarkably receptive to these issues and expressed strong concern about the dire consequences of COVID-19 on CKD patients. In the coming months, EKHA and EKPF will keep working with the European Commission to ensure that CKD patients’ needs, especially in the context of COVID-19, are placed high on the EU agenda.